Fidelity Investments’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Fidelity Investments’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,419	Closed	-$3.92K	–	5643
2022 Q4	$3.92K	Sell	4,419 -16,565	-79%	-$22K	﹤0.01%	4331
2022 Q3	$33K	Sell	20,984 -1,003	-5%	-$2.27K	﹤0.01%	3647
2022 Q2	$44K	Buy	21,987 +16,396	+293%	+$28.3K	﹤0.01%	3615
2022 Q1	$13K	Buy	+5,591	New	+$17.4K	﹤0.01%	4180
2021 Q3	–	Sell	-401	Closed	-$4K	–	5261
2021 Q2	$4K	Buy	+401	New	+$3.19K	﹤0.01%	3811
2018 Q4	–	Sell	-363,300	Closed	-$1.6M	–	4318
2018 Q3	$1.6M	Buy	+363,300	New	+$2.01M	﹤0.01%	2409
2017 Q2	–	Sell	-108,789	Closed	-$430K	–	2695
2017 Q1	$430K	Buy	+108,789	New	+$545K	﹤0.01%	2540
2016 Q1	–	Sell	-41,130	Closed	-$358K	–	2762
2015 Q4	$358K	Hold	41,130	–	–	﹤0.01%	2642
2015 Q3	$345K	Hold	41,130	–	–	﹤0.01%	2626
2015 Q2	$725K	Hold	41,130	–	–	﹤0.01%	2579
2015 Q1	$475K	Buy	+41,130	New	+$476K	﹤0.01%	2617
2014 Q4	–	Sell	-423,800	Closed	-$1.92M	–	2863
2014 Q3	$1.92M	Sell	423,800 -217,300	-34%	-$1.17M	﹤0.01%	2434
2014 Q2	$4.33M	Sell	641,100 -8,900	-1%	-$67.1K	﹤0.01%	2272
2014 Q1	$8.33M	Hold	650,000	–	–	﹤0.01%	2077
2013 Q4	$5.26M	Buy	+650,000	New	+$5.72M	﹤0.01%	2153

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Fidelity Investments's SRNE Position: Q1 2023 in Review

Fidelity Investments sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 4,419 shares — an estimated $3.92K sold.

Fidelity Investments first reported a position in SRNE in Q4 2013 and held it in 15 quarters. The position peaked at $8.33M in Q1 2014. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

Fidelity Investments reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Fidelity Investments sold 4,419 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $3.92K.
Fidelity Investments first reported a position in Sorrento Therapeutics, Inc. in Q4 2013 and held it in 15 quarters.
Fidelity Investments's Sorrento Therapeutics, Inc. position peaked at $8.33M in Q1 2014.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Fidelity Investments's 13F filing for Q1 2023, filed 11 May 2023.